Molecular Cancer

Peer-reviewed scientific journal

Academic journal

*Molecular Cancer*
Publication details
Discipline	Biology
Language	English
Edited by	Chi V. Dang
History	2002–present
Publisher	Springer Science+Business Media
Impact factor	41.444 (2021)
Standard abbreviations ISO 4 (alt) · Bluebook (alt1 · alt2) NLM (alt) · MathSciNet (alt )
ISO 4	Mol. Cancer
Indexing CODEN (alt · alt2) · JSTOR (alt) · LCCN (alt) MIAR · NLM (alt) · Scopus
ISSN	1476-4598
Links
Journal homepage Online archive

Molecular Cancer is a peer-reviewed open-access scientific journal covering all aspects of cancer research.

The journal is published by BioMed Central and was established in 2002. The editor-in-chief is Chi V. Dang, who is also the scientific director of the Ludwig Institute for Cancer Research.^[1]

Molecular Cancer publishes research articles, reviews, and commentaries related to cancer biology, molecular oncology, cancer genetics, epigenetics, signal transduction, and targeted therapy.^[2]

Abstracting and indexing

The journal is indexed in PubMed, and Scopus.^[3] The journal has a 2021 impact factor of 41.444, according to the Journal Citation Reports.^[4]

References

^ "Ludwig Cancer Research". Retrieved 2023-02-19.
^ "Molecular Cancer". BioMed Central. Retrieved 2023-02-19.
^ "Source details: Molecular Cancer". Scopus Preview. Elsevier. Retrieved 2023-02-12.
^ "Molecular Cancer". 2021 Journal Citation Reports. Web of Science (Science ed.). Clarivate. 2022.